Strand Therapeutics Inc.
2 clinical trials · Sponsor
◉ Watch Strand Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab (NCT07751042) | Strand Therapeutics Inc. | 2026-06-30 |
| Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab (NCT06249048) | Strand Therapeutics Inc. | 2024-05-03 |
Track Strand Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.